History of ductal carcinoma in situ icd 10

B20 Human immunodeficiency virus [HIV] disease with other diseases B97.33, B97.34,
B97.35 Human T-cell lymphotrophic virus,( type I [HTLV-1], type II [HTLV-II], type 2 [HIV 2]) as the cause of diseases classified elsewhere B97.7 Papillomarvirus as the cause of diseases classified elsewhere C44.01, C44.02 Basal/squamous cell carcinoma of skin of lip C44.11_, C44.12_ Basal/squamous cell carcinoma of skin of eyelid C44.21-, C44.22- Basal/squamous cell carcinoma of skin of ear and external auricular canal C44.31-, C44.32- Basal/squamous cell carcinoma of skin of other and unspecified parts of face C44.41, C44.42 Basal/squamous cell carcinoma of skin of scalp and neck C44.51-, C44.52- Basal/squamous cell carcinoma of skin of trunk C44.61-, C44.62- Basal/squamous cell carcinoma of skin of upper limb, including shoulder C44.71-, C44.72- Basal/squamous cell carcinoma of skin of lower limb, including hip C44.81, C44.82 Basal/squamous cell carcinoma of skin of overlapping sites of skin C44.91, C44.92 Basal/squamous cell carcinoma of skin of unspecified sites of skin D10.- - D31.-,
D34, D35.0,
D35.1, D35.5-
D35.9, D36.- Benign neoplasms (see "must collect" list for reportable benign neoplasms)
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
Note: Borderline cystadenomas M-8442, 8451, 8462, 8472, 8473, of the ovaries moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. SEER registries are not required to collect these cases for diagnoses made 1/1/2001 and after. However, cases diagnosed prior to 1/1/2001 should still be abstracted and reported to SEER. D3A._ Benign carcinoid tumors D37._ - D41._ Neoplasms of uncertain or unknown behavior (see "must collect" list for reportable neoplasms of uncertain or unknown behavior)
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors D44.0 - D44.2,
D44.6-D44.9 Neoplasm of uncertain or unknown behavior of other endocrine glands (see "must collect" list for D44.3-D44.5)
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors D47.01 Cutaneous mastocytosis (9740/1)
Note: Effective 10/1/2017 D47.09 Other mast cell neoplasms of uncertain behavior
Note: Effective 10/1/2017 D47.2 Monoclonal gammopathy
Note: Screen for incorrectly coded Waldenstrom's macroglobulinemia D47.Z2 Castleman disease D48.- Neoplasm of uncertain behavior of other and unspecified sites D49.0 - D49.9 Neoplasm of unspecified behavior (except for D49.6 and D49.7) D61.1 Drug-induced aplastic anemia (also known as “aplastic anemia due to antineoplastic chemotherapy”)
ICD-10-CM Coding instruction note: Use additional code for adverse effect, if applicable, to identify drug D61.810 Antineoplastic chemotherapy induced pancytopenia D61.82 Myelophthisis
ICD-10-CM Coding instruction: Code first the underlying disorder, such as: malignant neoplasm of breast (C50._) D63.0 Anemia in neoplastic disease
ICD-10-CM Coding instruction: Code first neoplasm (C00-C49) D64.81 Anemia due to antineoplastic chemotherapy D69.49, D69.59,
D69.6 Other thrombocytopenia
Note: Screen for incorrectly coded thrombocythemia D70.1 Agranulocytosis secondary to cancer chemotherapy
ICD-10-CM Coding instruction: Code also underlying neoplasm D72.1 Eosinophilia
(Note: Code for eosinophilia (9964/3). Not every case of eosinophilia is a malignancy. Reportable Diagnosis is "Hypereosonophilic syndrome.") D75.81 Myelofibrosis (note: this is not primary myelofibrosis [9961/3]
ICD-10-CM Coding instruction note: Code first the underlying disorder, such as: malignant neoplasm of breast (C50._) D76.- Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue D89.0, D89.1 Other disorders involving the immune mechanism, not elsewhere classified
Note: Review for miscodes D89.4- Mast cell activation syndrome and related disorders
Note: Effective 10/1/2016 E08 Diabetes mellitus due to underlying condition
ICD-10-CM Coding instruction note: Code first the underlying condition, such as: malignant neoplasm (C00-C96) E31.2- Multiple endocrine neoplasia [MEN] syndromes
ICD-10-CM Coding instruction: Code also any associated malignancies and other conditions associated with the syndromes E34.0 Carcinoid syndrome
ICD-10-CM Coding instruction: May be used as an additional code to identify functional activity associated with a carcinoid tumor E83.52 Hypercalcemia E88.09 Other disorders of plasma-protein metabolism, not elsewhere classified E88.3 Tumor lysis syndrome (following antineoplastic chemotherapy) G13.0 Paraneoplastic neuromyopathy and neuropathy
ICD-10-CM Coding instruction note:: Code first underlying neoplasm (C00-D49) G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease
ICD-10-CM Coding instruction note:: Code first underlying neoplasm (C00-D49) G32.8 Other specified degenerative disorders of nervous system in diseases classified elsewhere
ICD-10-CM Coding instruction note: Code first underlying disease, such as: cerebral degeneration (due to) neoplasm (C00-D49) G53 Cranial nerve disorders in diseases classified elsewhere
Note: Code first underlying neoplasm (C00-D49) G55 Nerve root and plexus compressions in diseases classified elsewhere
ICD-10-CM Coding instruction note: Code also underlying disease, such as neoplasm (C00-D49) G63 Polyneuropathy in diseases classified elsewhere
ICD-10-CM Coding instruction note: Code first underlying disease, such as: neoplasm (C00-D49) G73.1 Lambert-Eaton syndrome in neoplastic disease
ICD-10-CM Coding instruction: Code first underlying neoplasm (C00-D49) G89.3 Neoplasm related pain (acute)(chronic) G99.2 Myelopathy in diseases classified elsewhere
ICD-10-CM Coding instruction: Code first underlying disease, such as: neoplasm (C00-D49) H47.42 Disorders of optic chiasm in (due to) neoplasm
ICD-10-CM Coding instruction: Code also underlying condition H47.52- Disorders of visual pathways in (due to) neoplasm
ICD-10-CM Coding instruction: Code also underlying condition H47.63- Disorders of visual cortex in (due to) neoplasm
ICD-10-CM Coding instruction: Code also underlying condition J34.81 Nasal mucositis (ulcerative) J91.0 Malignant pleural effusion
ICD-10-CM Coding instruction: Code first underlying neoplasm J93.12 Secondary spontaneous pneumothorax
ICD-10-CM Coding instruction: Code first underlying condition, such as:
Malignant neoplasm of bronchus and lung (C34._)
Secondary malignant neoplasm of lung (C78.0_) K12.31 Oral mucositis (ulcerative) due to antineoplastic therapy K12.33 Oral mucositis (ulcerative) due to radiation K22.711 Barrett's esophagus with high grade dysplasia K62.7 Radiation proctitis K62.82 Dysplasia of anus (AIN I and AIN II) K92.81 Gastrointestinal mucositis (ulcerated) (due to antineoplastic therapy) M36.0 Dermato(poly)myositis in neoplastic disease
ICD-10-CM Coding instruction: Code first underlying neoplasm (C00-D49) M36.1 Arthropathy in neoplastic disease
ICD-10-CM Coding instruction: Code first underlying neoplasm, such as:
Leukemia (C91-C95), malignant histiocytosis (C96.A), multiple myeloma (C90.0) M84.5- Pathologic fracture in neoplastic disease
ICD-10-CM Coding instruction: Code also underlying neoplasm (C00-D49) M90.6- Osteitis deformans in neoplastic disease
ICD-10-CM Coding instruction: Code first the neoplasm (C40._, C41._) N42.3 Dysplasia of prostate (PIN I and PIN II) N76.81 Mucositis (ulcerative) of vagina and vulva N87.- Dysplasia of cervix uteri (CIN I and CIN II) N89.0, N89.1,
N89.3 Vaginal dysplasia (VIN I and VIN II) N90.0, N90.1,
N90.3 Vulvar dysplasia (VAIN I and VAIN II) O01.- Hydatidiform mole Note: Benign tumor that can become malignant. If malignant, report as Choriocarcinoma (9100/3, ) malignancy code in the C00- C97 range O9A.1- Malignant neoplasm complicating pregnancy, childbirth and the puerperium (conditions in C00-C96)
ICD-10-CM Coding instruction: Use additional code to identify neoplasm Q85.0- Neurofibromatosis (nonmalignant) (9540/1)
Note: Neurofibromatosis is not cancer. These tumors can be precursors to acoustic neuromas, which are reportable R18.0 Malignant ascites
ICD-10-CM Coding instruction: Code first malignancy, such as:
Malignant neoplasm of ovary (C56._), secondary malignant neoplasm of retroperitoneum and peritoneum (C78.6) R53.0 Neoplastic (malignant) related fatigue
ICD-10-CM Coding instruction: Code first associated neoplasm R59.- Enlarged lymph nodes R85.6- Abnormal findings on cytological and histological examination of digestive organs
Note: see "must collect" list for R85.614 R87.61-, R87.62- Abnormal findings on cytological/histological examination of female genital organs
Note: see "must collect" list for R87.614 and R87.624 R92.- Abnormal findings on diagnostic imaging of breast R97.- Abnormal tumor markers T38.6- Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified T38.8-, T38.9- Poisoning by hormones and their synthetic substitutes T45.1- Poisoning by, adverse effect of and under dosing of antineoplastic and immunosuppressive drugs T45.8-, T45.9- Poisoning by primary systemic and hematological agent, unspecified T66 Unspecified effects of radiation T80.1 Vascular complications following infusion, transfusion and therapeutic injection T80.2- Infections following infusion, transfusion and therapeutic injection T80.810 Extravasation of vesicant antineoplastic chemotherapy T80.818 Extravasation of other vesicant agent T86.0 Complications of bone marrow transplant
ICD-10-CM Coding instruction: Use addition code to identify other transplant complications, such as: malignancy associated with organ transplant (C80.2) or post-transplant lymphoproliferative disorders (PTLD) (D47.Z1) Y63.2 Overdose of radiation given during therapy Y84.2 Radiological procedure and radiotherapy as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure Z03.89 Encounter for observation for other suspected diseases and conditions ruled out Z08 Encounter for follow-up examination after completed treatment for malignant neoplasm (medical surveillance following completed treatment)
ICD-10-CM Coding instruction: Use additional code to identify the personal history of malignant neoplasm (Z85._) Z12.- Encounter for screening for malignant neoplasms Z13.0 Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism Z15.0 Genetic susceptibility to malignant neoplasm
ICD-10-CM Coding instruction: Code first, if applicable, any current malignant neoplasm (C00-C75, C81-C96); Use additional code, if applicable, for any personal history of malignant neoplasm (Z85._) Z17.0, Z17.1 Estrogen receptor positive and negative status
ICD-10-CM Coding instruction: Code first malignant neoplasm of breast (C50._) Z40.0- Encounter for prophylactic surgery for risk factors related to malignant neoplasms Z42.1 Encounter for breast reconstruction following mastectomy Z48.3 Aftercare following surgery for neoplasm
ICD-10-CM Coding instruction: Use additional code to identify the neoplasm Z48.290 Encounter for aftercare following bone marrow transplant Z51.0 Encounter for antineoplastic radiation therapy Z51.1- Encounter for antineoplastic chemotherapy and immunotherapy Z51.5, Z51.89 Encounter for palliative care and other specified aftercare Z79.81- Long term (current) use of agents affecting estrogen receptors and estrogen levels
ICD-10-CM Coding instruction: Code first, if applicable, malignant neoplasm of breast (C50._), malignant neoplasm of prostate (C61) Z80.- Family history of primary malignant neoplasm Z85._ Personal history of malignant neoplasm
ICD-10-CM Coding instruction: Code first any follow-up examination after treatment of malignant neoplasm (Z08) Z86.0-, Z86.01-,
Z86.03 Personal history of in situ and benign neoplasms and neoplasms of uncertain behavior Z92.21, Z92.23,
Z92.25. Z92.3 Personal history of antineoplastic chemotherapy, estrogen therapy, immunosuppression therapy or irradiation (radiation) Z94.81, Z94.84 Bone marrow and stem cell transplant status

What is the ICD

What is the ICD

What is the ICD

Can Z85 3 be a primary diagnosis?